Trollfors B, Norrby R, Kristianson K, Nilsson N J
Scand J Infect Dis Suppl. 1978(13):73-7.
The glomerular filtration rate measured by 51Chrome-EDTA and serum half life of cefoxitin were followed in patients with preexisting moderate renal impairment. The patients were treated with cefoxitin for two to three weeks because of chronic serious infections. The dose used in patients with an initial clearance of more than 40 mg/ml was 1 g three times daily giving a mean peak concentration of 100 microgram/ml. Seven patients were treated with cefoxitin alone and twelve with cefoxitin and furosemide (80 mg daily orally). The glomerular filtration rate did not change significantly during treatment time. There were no signs of accumulation of cefoxitin as serum half life of the drug remained unchanged both in patients treated with and without furosemide concurrently.
对已有中度肾功能损害的患者,随访了用51铬-依地酸测定的肾小球滤过率及头孢西丁的血清半衰期。因慢性严重感染,这些患者接受了两至三周的头孢西丁治疗。初始清除率超过40mg/ml的患者使用的剂量为每日三次,每次1g,平均峰浓度为100μg/ml。7例患者单独接受头孢西丁治疗,12例患者接受头孢西丁和呋塞米(每日口服80mg)治疗。治疗期间肾小球滤过率无显著变化。无论是否同时使用呋塞米治疗,药物的血清半衰期均未改变,没有头孢西丁蓄积的迹象。